Weill Cornell Medicine was awarded a $61.9 million grant from the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS) to continue funding its Clinical and Translational Science Center (CTSC) until 2027.
The fourth annual NYC Health Hackathon brought together students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus and several local and national academic institutions, to develop high-tech healthcare innovations.
The third annual NYC Health Hackathon brought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations.
Dr. Anaïs Rameau is passionate about finding a way to restore these patients’ voices and, during Weill Cornell Medicine’s second annual Health Innovation Hackathon last month, challenged participants to do just that.
Antibiotic treatment for Tuberculosis dramatically reduces quantities of several bacteria associated with immune system functions for at least a year, according to a study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program to continue funding its multi-institutional Clinical and Translational Science Center until 2022.
When Dr. Olorunseun Ogunwobi, an associate professor of biology at Hunter College and adjunct assistant professor at Weill Cornell Medicine needed African-American men to participate in his research on how genetics might play a role in prostate cancer disparities, he reached out to a well-known Bronx community leader to help him establish relationships with potential participants.